Research Tools and Online Resources
Discover helpful tools for advancing your rare and orphan disease research.
Each rare and orphan disease affects fewer than 200,000 individuals in the United States, and approximately 7,000 rare diseases have been described to date. The Jackson Laboratory offers the world's largest collection of spontaneous, targeted, and transgenic mutant mouse strains, hundreds of which model rare diseases.
Discover helpful tools for advancing your rare and orphan disease research.
The Rare Disease Translational Center brings together global mouse resources and the expertise of scientists at the Jackson Laboratory for a start-to-finish approach to model development.
Cat Lutz, Ph.D., M.B.A. was recently named vice president of the Rare Disease Translational Center at The Jackson...
The Jackson Laboratory is proud to announce the 2022 recipients of the JAX Postdoctoral Scholar award. Eric Bogenschutz, Jayna Mistry, and...
Resources for people who are interested in learning more about rare diseases, clinical trials, and research programs.
Rare and Orphan Disease Research Tools and Online Resources
With leading scientists, international networking, precision animal models, and next-generation genetics and genomics technologies, The...
Efficacy studies are performed by JAX on mouse models for these diseases: C57BL10.mdx and D2.mdx for DMD, DyW for CMD1A, and A/J for...
In honor for International Myotonic Dystrophy Awareness Day 2021, JAX's Laurent Bogdanik discusses the disease and potential...
Families have banded together from across the globe to make awareness and research for SMARD a reality.
Did you know that almost all of us have the sort of genetic mutations that cause rare genetic diseases?
Using the right mouse model can reveal various biological intricacies and may lead to potential therapeutic treatments. In a recent study,...
JAX distributes well-characterized, preclinical mouse models to accelerate drug discovery for rare and orphan diseases.
We partner with foundations, pharmaceutical and biotech companies, and other scientists to research treatments for uncommon...
Chris Brannigan is preparing to take off his boots and walk nearly 1200 miles down the eastern seaboard of the United...
JAX has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a new $17M contract with the...
JAX Professor Robert Burgess and collaborators are developing personalized gene therapy for a Texas child suffering from a neuromuscular...
New five-year NIH grant totaling $10.6M funds JAX center to fast-track treatment-focused research for rare genetic...